Clinical Trial Update: Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine [Phase 2]

View source ↗

Summary

A Phase 2 trial of Tezampanel for acute migraine has completed, reporting on safety, tolerability, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Tezampanel (tezampanel)

Snippet

Sponsor: TorreyPines Therapeutics | Conditions: Migraine | Phase 2 | Status: COMPLETED